参考文献/References:
［1］ Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase NO.10.Lyon, France: International Agency for Research on Cancer［OL］.http://globacan.iarc.fr.2010.
［2］ 中国抗癌协会肝癌专业委员会， 中国抗癌协会临床肿瘤学协作专业委员会，中华医学会肝病学分会肝癌学组. 原发性肝癌规范化诊治的专家共识［J］. 中华肝脏病杂志， 2009， 17： 403- 410.
［3］ 陈敏华， 董家鸿. 肝癌消融治疗： 现状、问题及应用前景［J］. 中华肝脏病杂志， 2012， 20： 241- 244.
［4］ Kudo M, Okanoue T. Management of hepatocellular carcinoma in Japan: consensus- based clinical practice manual proposed by the Japan Society of Hepatology［J］. Oncology, 2007, 72（Suppl 1）: 2- 15.
［5］ 陈敏华， 严 昆， 杨 薇， 等. 343例肝恶性肿瘤射频消融疗效及并发症［J］. 北京大学学报?医学版， 2005， 37： 292- 296.
［6］ 杨 薇， 陈敏华. 射频消融治疗肝肿瘤疗效及其影响因素［J］.中华医学杂志， 2005， 85： 354- 357.
［7］ Goldberg SN, Stein MC, Gazelle GS, et al. Percutaneous radiofre- quency tissue ablation: optimization of pulsed- radiofrequency technique to increase coagulation necrosis［J］. J Vasc Interv Radiol, 1999, 10: 907- 916.
［8］ de Baere T, Bessoud B, Dromain C, et al. Percutaneous radiofre- quency ablation of hepatic tumors during temporary venous occlusion［J］. AJR Am J Roentgenol, 2002, 178: 53- 59.
［9］ Patterson EJ, Scudamore CH, Owen DA, et al. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size［J］. Ann Surg, 1998, 227: 559- 565.
［10］ Nishizaki T, Takenaka K, Yoshida K, et al. Influence of lipiodoli- zation on a cirrhotic liver［J］. J Surg Oncol, 1995, 58: 263- 268.
［11］ Shibata T, Isoda H, Hirokawa Y, et al. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?［J］. Radiology, 2009, 252: 905- 913.
［12］ Takahashi S, Kudo M, Chung H, et al. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy［J］. Oncology, 2007, 72: 98- 103.
［13］ Kim JW, Kim JH, Won HJ, et al. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofre- quency ablation vs. radiofrequency ablation alone［J］. Eur J Radiol, 2012, 81: e189- e193.
［14］ Wang W, Shi J, Xie WF. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta- analysis［J］. Liver Int, 2010, 30: 741- 749.
［15］ Kirikoshi H, Saito S, Yoneda M, et al. Outcome of transarterial chemoembolization monotherapy, and in combination with percutaneous ethanol injection, or radiofrequency ablation therapy for hepatocellular carcinoma［J］. Hepatol Res, 2009, 39: 553- 562.
［16］ Duan X, Zhou G, Han X, et al. Radiofrequency ablation combined with transcatheter therapy in rabbit VX2 liver tumors: effects and histopathological characteristics［J］. Acta Radiol, 2015, 56: 87- 96.
［17］ Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US- guided radio- frequency tissue ablation of liver metastases: treatment and follow- up in 16 patients［J］. Radiology, 1997, 202: 195- 203.
［18］ 吴沛宏， 张福君， 赵 明， 等. 肝动脉栓塞化疗联合CT导向射频消融术治疗中、晚期肝癌的评价［J］. 中华放射学杂志， 2003， 37： 901- 904.
［19］ 沈 理， 陈敏华， 严 昆， 等. 探讨经皮射频消融联合肝动脉化学栓塞治疗大肝癌的临床应用效果［J］. 中华超声影像学杂志， 2004， 13： 577- 580.
［20］ Hompes D, Prevoo W, Ruers T. Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin［J］. Cancer Imaging, 2011, 11: 23- 30.
［21］ Gonda T, Ishida H, Yoshinaga K, et al. Microvasculature of small liver metastases in rats［J］. J Surg Res, 2000, 94: 43- 48.
［22］ 时高峰， 王士杰， 王 琦， 等. CT灌注成像在研究大鼠微小肝转移癌血供中的作用［J］. 癌症， 2006， 25： 849- 854.
［23］ Liu Y, Matsui O. Changes of intratumoralmicrovessels and blood perfusion during establishment of hepatic metastases in mice［J］. Radiology, 2007, 243: 386- 395.
［24］ 王 健， 佟小强， 宋 莉， 等. 射频消融联合肝动脉化疗栓塞治疗肝转移癌［J］. 中华放射学杂志， 2011， 45： 662- 665.
［25］ 李国文， 梁赵玉， 于小平， 等. 肝动脉化疗栓塞联合射频消融治疗肝转移瘤［J］. 当代医学， 2010， 16： 305- 308.
［26］ Yamakado K, Nakatsuka A, Ohmori S, et al. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology［J］. J Vasc Interv Radiol, 2002, 13: 1225- 1232.
［27］ 宋 莉， 佟小强， 王 健， 等. 碘化油肝动脉栓塞对灌注型射频消融的影响： 实验研究［J］. 中国介入影像与治疗学， 2010， 7： 181- 184.
［28］ Arata S, Tanaka K, Okazaki H, et al. Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI［J］.Hepatogastroenterology, 2001, 48: 480- 485.
［29］ 范卫君， 赵 明， 吴沛宏， 等. 经皮射频消融术在肝肿瘤治疗中的临床价值［J］. 中华放射学杂志， 2002， 36， 313- 320.
［30］ Bartolozzi C, Lencioni R, Caramella D, et al. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization［J］. Radiology, 1995, 197: 812- 818.
［31］高松学. 肝动脉化疗栓塞术联合射频消融治疗肝癌的现状［J］. 中国介入影像与治疗学， 2010， 7： 680- 683.
［32］ Takaki H, Yamakado K, Uraki J, et al. Radiofrequency ablation combined with chemoembolization for the treatment of hepato- cellular carcinomas larger than 5 cm［J］. J Vasc Interv Radiol, 2009, 20: 217- 224.
［33］ 方志雄， 程 丹， 方志宏， 等. 肝动脉化疗栓塞联合射频消融治疗大肝癌疗效评价［J］. 中华临床医师杂志?电子版， 2012， 6： 203- 205.
［34］ 周启明， 吴沛宏， 赵 明， 等. 原发性肝癌经综合微创治疗后联合细胞因子诱导杀伤细胞灌注的近期疗效观察［J］. 癌症， 2006， 25： 1414- 1418.
［35］ Gauthier A, Ho M. Role of sorafenib in the treatment of advanced hepatocellular carcinoma: an update［J］. Hepatol Res, 2013, 43: 147- 154.
［36］ Abou- Alfa GK. TACE and sorafenib: a good marriage?［J］. J Clin Oncol, 2011, 29: 3949- 3952.
［37］ 姚雪松， 闫 东， 曾辉英， 等. TACE联合索拉非尼治疗不能手术切除肝细胞肝癌50例［J］. 介入放射学杂志， 2013， 22： 381- 386.
［38］ 郭 青， 栾翠美， 李 岩， 等. TACE联p53基因瘤内注射治疗原发性肝癌的疗效观察［J］. 中国中西医结合影像学杂志， 2013， 11： 180- 182.
［39］ 熊 壮， 王建华. 溶瘤病毒在肝癌介入治疗中的应用［J］. 介入放射学志， 2007， 16： 206- 208.
［40］ 程洪涛， 郭晨阳， 黎海亮， 等. TACE联合射频消融治疗原发性肝癌疗效的影响因素分析［J］. 介入放射学杂志， 2012， 21： 216- 219.
［41］ Dodd GD 3rd, Soulen MC, Kane RA, et al. Minimally invasive treatment of malignant hepatic tumors at the threshold of a major break through［J］. Raidiographics, 2000, 20: 9- 27．
［42］ 姚红响， 陈根生， 诸葛英， 等. 肝动脉化疗栓塞联合CT引导射频消融序贯治疗中小肝癌的临床应用［J］. 介入放射学杂志， 2012， 21： 301- 304.
相似文献/References:
[1]蒲红.上海市第二届射频消融疑难病例研讨会纪要[J].介入放射学杂志,1997,(01):63.
[2]蒲红,尹炯,王咏梅,等.显性间隔房室旁路的射频消融[J].介入放射学杂志,1997,(02):104.
[3]杨永波,程红岩.肝动脉化疗栓塞治疗中碘油用量的现状与研究进展[J].介入放射学杂志,2012,(04):348.
.Ｔｈｅ ｖｏｌｕｍｅ ｏｆ Ｌｉｐｉｏｄｏｌ ｕｓｅｄ ｉｎ ＴＡＣＥ： ｉｔｓ ｃｕｒｒｅｎｔ ｓｉｔｕａｔｉｏｎ ａｎｄ ｒｅｓｅａｒｃｈ ｐｒｏｇｒｅｓｓ [J].journal interventional radiology,2012,(03):348.
[4]罗荣光,黄金华.肿瘤射频消融：电极的类型和消融灶的特点[J].介入放射学杂志,2011,(02):159.
LUO Rong-guang,HUANG Jin-hua..Radiofrequency ablation of tumors: the relationship between the electrode type and the feature of ablated zone[J].journal interventional radiology,2011,(03):159.
[5]程洪涛,郭晨阳,黎海亮,等.ＴＡＣＥ联合射频消融治疗原发性肝癌疗效的影响因素分析[J].介入放射学杂志,2012,(03):216.
,,et al.ＴＡＣＥ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ＣＴｇｕｉｄｅｄ ｐｅｒｃｕｔａｎｅｏｕｓ ｒａｄｉｏｆｒｅｑｕｅｎｃｙ ａｂｌａｔｉｏｎ ｆｏｒ ｔｈｅ ｔｒｅａｔｍｅｎｔ ｏｆ ｐｒｉｍａｒｙ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ａｎ ａｎａｌｙｓｉｓ ｏｆ ｆａｃｔｏｒｓ ａｆｆｅｃｔｉｎｇ ｔｈｅ ｔｈｅｒａｐｅｕｔｉｃ ｒｅｓｕｌｔ [J].journal interventional radiology,2012,(03):216.
[6]姚红响,陈根生,诸葛英,等.肝动脉化疗栓塞联合ＣＴ引导射频消融序贯治疗中小肝癌的临床应用[J].介入放射学杂志,2012,(04):301.
,,et al.Ｓｅｑｕｅｎｔｉａｌ ｔｒｅａｔｍｅｎｔ ｗｉｔｈ ＴＡＣＥ ａｎｄ ＣＴｇｕｉｄｅｄ ＲＦＡ ｆｏｒ ｓｍａｌｌ ａｎｄ ｍｏｄｅｒａｔｅ ｓｉｚｅｄ ＨＣＣ [J].journal interventional radiology,2012,(03):301.
[7]朱先海,吕维富,鲁 东,等.超选择性肾动脉栓塞术联合射频消融治疗肾癌的临床应用[J].介入放射学杂志,2011,(07):541.
ZHU Xian-hai,LV Wei-fu,LU Dong,et al.Superselective renal artery embolization combined with radiofrequency ablation for the treatment of renal carcinomas: evaluation of clinical results[J].journal interventional radiology,2011,(03):541.
[8]谢小西,吕银祥,章宏欣,等. 肝动脉化疗栓塞、射频消融联合１２５Ⅰ粒子植入 治疗原发性肝癌的临床应用[J].介入放射学杂志,2011,(11):863.
XIE Xiao-xi,LV Yin-xiang,ZHANG Hong-xin,et al.The clinical application of TACE together with RFA and 125Ⅰ seed implantation in treating hepatocellular carcinoma[J].journal interventional radiology,2011,(03):863.
[9]张 磊,陆骊工,李 勇,等.门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究[J].介入放射学杂志,2011,(12):968.
ZHANG Lei,LU Li-gong,LI Yong,et al.Portal vein stent placement combined with TACE for the treatment of hepatocellular carcinoma associated with tumor thrombus in portal vein[J].journal interventional radiology,2011,(03):968.
[10]李建军,郑加生,崔雄伟,等. 肝肿瘤CT引导经皮射频消融术后胆道并发症防治[J].介入放射学杂志,2011,(12):984.
LI Jian-jun,ZHENG Jia-sheng,CUI Xiong-wei,et al.The prevention and treatment of biliary complications occurred after CT-guided percutaneous radiofrequency ablation for hepatic neoplasms[J].journal interventional radiology,2011,(03):984.
[11]帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗３０例原发性大肝癌的疗效评价[J].介入放射学杂志,2012,(04):322.
,,et al.ＴＡＣＥ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ｒａｄｉｏｆｒｅｑｕｅｎｃｙ ａｂｌａｔｉｏｎ ｆｏｒ ｍａｓｓｉｖｅ ｐｒｉｍａｒｙ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ａ ｃｌｉｎｉｃａｌ ｔｈｅｒａｐｅｕｔｉｃ ｅｖａｌｕａｔｉｏｎ [J].journal interventional radiology,2012,(03):322.
[12]彭国文,李晓群. 射频消融及组合方案治疗特殊/高危部位肝癌的中远期疗效[J].介入放射学杂志,2013,(06):525.
PENG Guo? wen,LI Xiao? qun.. The mid?蛳 to?蛳 long term efficacy of radiofrequency ablation together with combination regimen for the treatment of hepatic carcinomas located at special or high?蛳 risk regions[J].journal interventional radiology,2013,(03):525.
[13]管清龙,任伟新,纪卫政.肝癌治疗后血清内血管内皮生长因子对预后影响的研究进展[J].介入放射学杂志,2013,(08):701.
GUAN Qing? long,REN Wei? xin,JI Wei? zheng..The impact of serum vascular endothelial growth factor expression on the prognosis in patients with hepatocellular carcinoma after treatment： recent progress in clinical research[J].journal interventional radiology,2013,(03):701.
[14]陈付文,郑春生,黄柿兵,等.肝动脉化疗栓塞联合射频消融治疗大肝癌的临床观察[J].介入放射学杂志,2015,(08):684.
CHEN Fu- wen,ZHENG Chun- sheng,HUANG Shi- bing,et al.TACE combined with RFA for the treatment of massive primary hepatocellular carcinomas： observation of clinical efficacy and safety[J].journal interventional radiology,2015,(03):684.
[15]任衍乔,郑传胜.肝癌射频消融术后各种影像学评价应用与进展 [J].介入放射学杂志,2018,27(10):993.
REN Yanqiao,ZHENG Chuansheng..Different imaging assessments for hepatocellular carcinoma after radiofrequency ablation： clinical application and recent progress[J].journal interventional radiology,2018,27(03):993.
[16]黄职妹,宁额尔敦巴格,李 慧,等.CT引导下人工腹水结合三维可视化系统辅助射频消治疗难消融复发性肝癌 [J].介入放射学杂志,2022,31(04):387.
HUANG Zhimei,NING Eerdunbage,LI Hui,et al.CT-guided artificial ascites combined with three-dimensional visualization system-assisted radiofrequency ablation for refractory recurrent hepatocellular carcinoma[J].journal interventional radiology,2022,31(03):387.